Literature DB >> 11254783

Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries.

K Fassbender1, B Hodapp, S Rossol, T Bertsch, J Schmeck, S Schütt, M Fritzinger, P Horn, P Vajkoczy, S Kreisel, J Brunner, P Schmiedek, M Hennerici.   

Abstract

Subarachnoidal release of inflammatory cytokines (interleukin (IL)-1beta, IL-6, and tumour necrosis factor (TNF)-alpha) was characterised in 35 patients with subarachnoid haemorrhage (SAH) and control subjects and compared with development of complicating haemodynamic abnormalities in basal cerebral arteries and clinical outcome. Serial analysis allowed the observation of a subacute response profile of these key mediators of inflammation in the subarachnoidal space. This compartmentalised inflammatory host response was closely associated in time and extent with development of increased blood flow velocities in the basal cerebral vessels as recorded by transcranial Doppler sonography. Moreover, intrathecal secretion of inflammatory cytokines was significantly increased in patients with poor clinical outcome. Together, these findings suggest a role of excessive compartmentalised inflammatory host response in pathogenesis of cerebrovascular complications after SAH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254783      PMCID: PMC1737308          DOI: 10.1136/jnnp.70.4.534

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  98 in total

1.  Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm.

Authors:  Elisa R Zanier; Giovanna Brandi; Giuseppe Peri; Luca Longhi; Tommaso Zoerle; Mauro Tettamanti; Cecilia Garlanda; Anna Sigurtà; Serenella Valaperta; Alberto Mantovani; Maria Grazia De Simoni; Nino Stocchetti
Journal:  Intensive Care Med       Date:  2010-11-12       Impact factor: 17.440

2.  Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage.

Authors:  Asita Sarrafzadeh; Florian Schlenk; Christine Gericke; Peter Vajkoczy
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

Review 3.  Endocannabinoids in cerebrovascular regulation.

Authors:  Zoltán Benyó; Éva Ruisanchez; Miriam Leszl-Ishiguro; Péter Sándor; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-29       Impact factor: 4.733

Review 4.  Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target?

Authors:  Aisha R Saand; Fang Yu; Jun Chen; Sherry H-Y Chou
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-08       Impact factor: 6.200

Review 5.  The role of the microglia in acute CNS injury.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Metab Brain Dis       Date:  2014-03-29       Impact factor: 3.584

Review 6.  Phenotypic transformation of smooth muscle in vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Norihito Shimamura; Hiroki Ohkuma
Journal:  Transl Stroke Res       Date:  2013-11-20       Impact factor: 6.829

7.  Cerebral lactate correlates with early onset pneumonia after aneurysmal SAH.

Authors:  S Radolf; N Smoll; C Drenckhahn; J P Dreier; P Vajkoczy; A S Sarrafzadeh
Journal:  Transl Stroke Res       Date:  2013-10-17       Impact factor: 6.829

Review 8.  Targeting TLR4-dependent inflammation in post-hemorrhagic brain injury.

Authors:  Jason K Karimy; Benjamin C Reeves; Kristopher T Kahle
Journal:  Expert Opin Ther Targets       Date:  2020-04-17       Impact factor: 6.902

9.  CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage.

Authors:  J J Provencio; X Fu; A Siu; P A Rasmussen; S L Hazen; R M Ransohoff
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

10.  Cerebral ischemia induces transcription of inflammatory and extracellular-matrix-related genes in rat cerebral arteries.

Authors:  Petter Vikman; Saema Ansar; Marie Henriksson; Emelie Stenman; Lars Edvinsson
Journal:  Exp Brain Res       Date:  2007-09-08       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.